Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$29.75 Web:$26.78 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles The Learning Healthcare System: Workshop Summary (IOM Roundtable on Evidence-Based Medicine) Safe Medical Devices for Children Other Related Titles Innovation and Invention in Medical Devices: Workshop Summary (2001) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 71   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix A Workshop Agenda Roundtable on Research and Development of Drugs, Biologics, and Medical Devices INNOVATION AND INVENTION IN MEDICAL DEVICES 17–18 FEBRUARY 2000 WYNDHAM CITY CENTER HOTEL 1143 NEW HAMPSHIRE AVENUE, N.W. WASHINGTON, D.C. AGENDA Thursday, 17 February 7:30 a.m. Continental Breakfast Opening Session 8:00 Welcome and Opening Remarks Kenneth I.Shine, M.D., President Institute of Medicine 8:15 Statement of Objectives, Charge to Participants, Introductions Ronald W.Estabrook, Ph.D., Roundtable Chair Virginia Lazenby O’Hara Professor of Biochemistry University of Texas Southwestern Medical Center 8:30 Opening Remarks Kshitij Mohan, Ph.D., Workshop Chair Corporate Vice President for Research and Technical Services Baxter Health Care Corporation Page 71 Front Matter (R1-R20) 1 Introductory Overview (1-8) 2 Keynote Session (9-30) 3 The Nature of Medical Innovation (31-46) 4 Sources and Support of Medical Devices Innovation (47-60) 5 The Challenges Ahead (61-68) 6 Summary and Conclusions (69-70) Appendix A: Workshop Agenda (71-76) Appendix B: Speakers' Biographical Sketches (77-88) Appendix C: Registered Participants (89-92)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 71
Innovation and Invention in Medical Devices: Workshop Summary Appendix A Workshop Agenda Roundtable on Research and Development of Drugs, Biologics, and Medical Devices INNOVATION AND INVENTION IN MEDICAL DEVICES 17–18 FEBRUARY 2000 WYNDHAM CITY CENTER HOTEL 1143 NEW HAMPSHIRE AVENUE, N.W. WASHINGTON, D.C. AGENDA Thursday, 17 February 7:30 a.m. Continental Breakfast Opening Session 8:00 Welcome and Opening Remarks Kenneth I.Shine, M.D., President Institute of Medicine 8:15 Statement of Objectives, Charge to Participants, Introductions Ronald W.Estabrook, Ph.D., Roundtable Chair Virginia Lazenby O’Hara Professor of Biochemistry University of Texas Southwestern Medical Center 8:30 Opening Remarks Kshitij Mohan, Ph.D., Workshop Chair Corporate Vice President for Research and Technical Services Baxter Health Care Corporation

OCR for page 72
Innovation and Invention in Medical Devices: Workshop Summary 8:45 Plenary Speaker Harry M.Jansen Kraemer, Jr. Chairman and Chief Executive Officer Baxter International, Inc. Keynote Session Innovation and invention-related perspectives of key stakeholders (research, clinical practice, regulatory, industry, and consumer constituencies) in the area of medical devices. Past, present, and future directions in medical devices. Moderator: Ronald W.Estabrook, Ph.D., Roundtable Chair 9:30 Robert W.Mann, Sc.D. Whitaker Professor Emeritus of Biomedical Engineering Massachusetts Institute of Technology 9:50 David W.Feigal, M.D., M.P.H. Director, Center for Devices and Radiological Health Food and Drug Administration 10:30 Tobias Massa, Ph.D. Executive Director, Global Regulatory Affairs Lilly Research Laboratories 10:50 Jeffrey C.Lerner Ph.D. Vice President for Strategic Planning ECRI 11:10 Glen D.Nelson, M.D. Vice Chairman Medtronic, Inc. 11:30 Panel Discussion Period Session I: The Nature of Medical Innovation Presentations in this session will provide the status of innovation in medical devices since the late 1980s, address the invention and development process map for medical device technologies and products, present case studies that analyze the factors which have led to significant medical device innovations in the past 50 years, and discuss the factors that have supported significant ongoing and emerging technology innovations to reach the development and clinical stage. Moderator: Annetine C.Gelijns, Ph.D. Director, International Center for Health Outcomes and Innovation Research Columbia University

OCR for page 73
Innovation and Invention in Medical Devices: Workshop Summary 1:30 p.m. Introductory Comments Annetine C.Gelijns, Ph.D. 1:50 The Innovation Process for Medical Devices: A NASA Perspective John Hines, M.S. Technology Development Manager Space Life Sciences Program, NASA 2:10 Case Studies of Significant Medical Device Innovation in the Past Thomas J.Fogarty, M.D. Professor of Surgery Stanford University School of Medicine 2:30 Case Studies of Significant Emerging Innovations Stephen P.A.Fodor, Ph.D. Chairman and Chief Executive Officer Affymetrix 3:10 Inhaled Insulin—A Case Study Robert B.Chess Chief Executive Officer Inhale Therapeutics 3:30 Case Studies of Significant Emerging Innovations Richard Nadeau, Ph.D. Chairman and Chief Executive Officer Cytometrics 3:50 Case Studies of Significant Emerging Innovations Dean Kamen President DEKA Research and Development Corporation 4:10 Panel Discussion Period 5:10 Adjournment Friday, 18 February 8:15 a.m. Opening Remarks Ronald Estabrook, Ph.D., Roundtable Chair Session II: Sources and Support of Medical Device Innovation Presentations in this session will analyze the sources and amount of resources available in the medical device innovation field; discuss the role of small, large, and multinational medical companies and identify the issues and

OCR for page 74
Innovation and Invention in Medical Devices: Workshop Summary opportunities confronted by them in this field, as well as the role of standards and product applications; identify the role as well as the incentives and drivers of venture capital; and discuss the role of the legal system. Moderator: James S.Benson Executive Vice President, Technology and Regulatory Affairs Health Industry Manufacturers Association 8:30 An Overview of Public and Private Factors Affecting Medical Device Innovation Cliff Goodman, Ph.D. Senior Scientist The Lewin Group 8:55 The Federal Research Role John T.Watson, Ph.D. Acting Deputy Director, National Heart, Lung and Blood Institute, NIH 9:15 The Federal Regulatory Role Susan Alpert, M.D., Ph.D. Director, Center for Food Safety and Applied Nutrition Food and Drug Administration 9:35 The Academic Role in Innovation John A.Parrish, M.D. Center for Innovative Minimally Invasive Technology Massachusetts General Hospital 10:20 The Academic Role Robert W.Anderson, M.D. David C.Sabiston Professor and Chair Department of Surgery Duke University 10:40 Role of Small Medical Companies Thomas M.Loarie Chief Executive Officer Kera Vision, Inc. 11:00 Role of Large Medical Companies John P.Wareham Chief Executive Officer Beckman Coulter 11:20 Role of Public and Private Capital J.Casey McGlynn Partner—Wilson, Sonsini, Goodrich and Rosati

OCR for page 75
Innovation and Invention in Medical Devices: Workshop Summary 11:40 Panel Discussion Period Session III: The Challenges Ahead Session III will examine the challenges that lie ahead for medical device innovation, such as identifying areas of clinical medicine where there are significant unmet clinical needs that may be addressed through innovation in medical technology and through training and education, as well as identifying new initiatives in interdisciplinary science for promoting new models for the conduct of research essential to the undergirding of future medical technology. This session will also discuss emerging discoveries and technologies that could serve as the basis for developing new medical devices, addressing the unmet clinical needs, or for improving costs or outcome of currently available devices, as well as identify the potential barriers for present and future technologies which are being applied to medical devices and identify the public perception of risk assessment. Moderator: Robert Califf, M.D., Roundtable Member Associate Vice Chancellor for Clinical Research Duke University 1:30 p.m. Unmet Clinical Needs Robert Califf, M.D. 1:55 Unmet Clinical Needs James E.Muller, M.D. Center for Innovative Minimally Invasive Therapy 2:20 Barriers and Issues in Device Innovation: Reimbursement Pamela G.Bailey President, Health Industry Manufacturers Association 2:45 Panel Discussion Period Summary and Conclusions 3:30 Summary and Conclusions Kshitij Mohan, Ph.D., Workshop Chair 4:00 Closing Remarks Ronald Estabrook, Ph.D., Roundtable Chair 4:20 Adjournment

OCR for page 76
Innovation and Invention in Medical Devices: Workshop Summary This page in the original is blank.

Representative terms from entire chapter:

medical devices